Ignite Creation Date:
2024-05-06 @ 3:29 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04649970
Status:
COMPLETED
Last Update Posted:
2020-12-04
First Post:
2020-11-24
Brief Title:
Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy
Sponsor:
Université de Sousse
Organization:
Université de Sousse
Study Overview
Official Title:
Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy a Single Center Experience
Status:
COMPLETED
Status Verified Date:
2020-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ureteral double- J stent is usually inserted by retrograde approach for the treatment of obstructed upper urinary tract The antegrade approach can a suitable alternative in certain situations without the need for general or spinal anesthesia The present study demonstrates the indications success rate and complications of this approach in the treatment of malignant obstructive uropathy
Detailed Description:
Data of consecutive patients in whom antegrade ureteral stenting was performed between January 2013 and February 2020 were retrospectively analysed using patient records and radiology reports A total of 174 patients sexe ratio 051 age range 9-91 years mean age 54 years were included in the study
Ureteral obstruction was caused by bladder cancer n92 uterin cancer n31 prostate cancer n28 colorectal cancer n 15 and retroperitoneal tumor n 8 Table 1
Ureteral obstruction was caused by bladder cancer n92 uterin cancer n31 prostate cancer n28 colorectal cancer n 15 and retroperitoneal tumor n 8 Table 1
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None